Getinge AB (publ) (STO:GETI.B)

Revenue Breakdown

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies Revenue	17.98B	18.68B	17.95B
Life Science Revenue	4.53B	4.50B	4.55B
Surgical Workflows Revenue	11.72B	11.80B	12.26B
Revenue (Other)	2.00M	-	1.00M
Revenue (Total)	34.24B	34.97B	34.76B

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Americas Revenue	15.12B	15.69B	15.52B
APAC Revenue	6.59B	6.94B	7.06B
EMEA Revenue	12.53B	12.34B	12.18B
Revenue (Total)	34.24B	34.97B	34.76B

Revenue Breakdown 2

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Capital Goods Revenue	11.43B	11.97B	12.42B
Product Sales Recurring Revenue	16.01B	16.19B	15.59B
Service Assignments Incl. Spare Parts Recurring Revenue	6.79B	6.82B	6.75B
Total Recurring Revenue	22.80B	23.00B	22.34B
Revenue (Total)	34.24B	34.97B	34.76B

Gross Profit

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies Gross Profit	10.32B	10.42B	9.62B
Life Science Gross Profit	1.58B	1.56B	1.70B
Surgical Workflows Gross Profit	4.75B	4.68B	4.84B
Gross Profit (Other)	-3.00M	-1.00M	-
Gross Profit (Total)	16.64B	16.65B	16.15B

EBIT

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies Operating Profit	3.36B	3.02B	2.07B
Life Science Operating Profit	546.00M	470.00M	526.00M
Surgical Workflows Operating Profit	893.00M	773.00M	703.00M
Group Functions and Other Items Operating Profit	-486.00M	-474.00M	-440.00M
Operating Income (Other)	-1.00M	-1.00M	-
Operating Income (Total)	4.31B	3.79B	2.85B

Adjusted EBITDA

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies Adjusted EBITA	3.87B	3.76B	3.55B
Life Science Revenue Adjusted EBITA	555.00M	490.00M	608.00M
Surgical Workflows Adjusted EBITA	1.20B	1.08B	1.09B
Group Functions and Other Items Adjusted EBITA	-434.00M	-450.00M	-383.00M
Operating Income (Other)	-874.00M	-1.09B	-2.02B
Operating Income (Total)	4.31B	3.79B	2.85B

Key Performance Indicators

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Acute Care Therapies - Order Intake	17.66B	18.22B	17.72B
Life Science - Order Intake	4.37B	4.25B	4.60B
Surgical Workflows - Order Intake	11.61B	11.55B	11.91B
Total Order Intake	33.64B	34.03B	34.23B
Order Intake - Organic Growth	-	3.50%	6.30%
Acute Care Therapies Net Sales - Organic Growth	-	7.00%	8.20%
Life Science Net Sales - Organic Growth	-	4.10%	-1.90%
Surgical Workflows Net Sales - Organic Growth	-	2.10%	2.60%
Total Net Sales Organic Growth	-	4.90%	4.90%

Data Source: Fiscal.ai Last updated: Jul 17, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error